10-Q: Centrus Energy Q3 Net Income Soars, Boosted by Investment Gains

Centrus Energy reports a significant increase in net income for Q3 2025, driven by higher investment income and a federal tax valuation allowance release, despite a decrease in LEU segment gross profit.

Summary

• Net income for Q3 2025 was $3.9 million, a substantial improvement from a $5.0 million loss in Q3 2024.
• Net income for the nine months ended September 30, 2025, reached $60.0 million, up from $19.5 million in the same period of 2024.
• Total revenue for Q3 2025 increased by 30% to $74.9 million from $57.7 million in Q3 2024.
• Total revenue for the nine months ended September 30, 2025, increased by 4% to $302.5 million from $290.4 million in the same period of 2024.
• LEU segment revenue increased by 29% in Q3 2025 to $44.8 million, primarily due to $34.1 million in uranium revenue, though SWU revenue decreased by $24.1 million (69%) due to a lower average price.
• Technical Solutions segment revenue increased by 31% in Q3 2025 to $30.1 million, mainly driven by a $7.3 million increase from the HALEU Operation Contract.
• Gross profit for the LEU segment resulted in a loss of $7.8 million in Q3 2025, down from a $5.2 million profit in Q3 2024.
• Gross profit for the Technical Solutions segment decreased by 5% to $3.5 million in Q3 2025.
• Investment income significantly increased to $12.9 million in Q3 2025 (from $2.6 million in Q3 2024) and to $28.2 million for the nine months (from $7.8 million).
• A federal tax valuation allowance of $10.2 million was released in Q3 2025, contributing to a higher income tax benefit.
• The company redeemed all 8.25% Notes in March 2025, recording an $11.8 million gain on extinguishment of long-term debt.
• Issued $805.0 million of 0% Convertible Notes due August 2032 in August 2025 and $402.5 million of 2.25% Convertible Notes due November 2030 in November 2024.
• The 2.25% Convertible Notes became convertible at holders' option from July 1, 2025, to September 30, 2025, and again from October 1, 2025, to December 31, 2025, due to the Class A Common Stock price exceeding 130% of the conversion price; however, no notes were converted.
• Total backlog increased to $3.9 billion as of September 30, 2025, from $3.7 billion at December 31, 2024, with commitments extending to 2040.
• The HALEU Operation Contract Phase 2 period of performance was extended through October 31, 2025, due to supply chain challenges with 5B Cylinders.
• The DOE exercised Option 1a of Phase 3 of the HALEU Operation Contract, extending performance to June 30, 2026, with a contract value of $108.2 million.
• Centrus announced plans for a major expansion of uranium capacity in Piketon, Ohio, for both LEU and HALEU, which is expected to be a multi-billion dollar private and public investment.
• Resumed centrifuge manufacturing activities and expanded capacity at Oak Ridge, Tennessee, with a $60.0 million investment over 18 months.
• The IRS granted a $62.4 million 48C clean energy tax credit allocation for the Oak Ridge manufacturing facility.

Sentiment

Score: 7

Explanation: The company reported strong net income growth and increased revenue, driven by investment income and a tax allowance release. It also secured significant funding for HALEU operations and a valuable tax credit. However, the core LEU segment's gross profit declined, and there are substantial geopolitical, supply chain, and financial risks associated with its reliance on Russian supply and large debt issuances. The long-term strategic initiatives for domestic enrichment are promising but require significant future funding and face execution challenges.

Positives

• Net income for Q3 2025 was $3.9 million, a significant improvement from a $5.0 million loss in Q3 2024, and $60.0 million for the nine months, up from $19.5 million in the prior year.
• Total revenue increased by 30% in Q3 2025 to $74.9 million and by 4% for the nine months to $302.5 million, indicating overall business growth.
• Investment income saw a dramatic increase of 396% in Q3 2025 to $12.9 million and 262% for the nine months to $28.2 million, significantly boosting profitability due to higher cash balances.
• The release of a $10.2 million federal tax valuation allowance positively impacted net income, reflecting an improved outlook for taxable income.
• A gain of $11.8 million was recorded from the extinguishment of the 8.25% Notes, improving the debt profile.
• Total backlog increased to $3.9 billion as of September 30, 2025, from $3.7 billion at December 31, 2024, providing long-term revenue visibility extending to 2040.
• The DOE exercised Option 1a of Phase 3 of the HALEU Operation Contract, securing $108.2 million in funding and extending work to June 30, 2026.
• The company was granted a $62.4 million 48C clean energy tax credit allocation for the Oak Ridge manufacturing facility, which can be monetized for cash.
• Resumption of centrifuge manufacturing and expansion in Oak Ridge, Tennessee, with a $60.0 million investment, supports future large-scale domestic enrichment.
• Centrus was among the awardees for all three DOE IDIQ RFPs (HALEU production, HALEU deconversion, and LEU production), with a $2.0 million contract minimum for each, indicating strong government partnership.
• Spot prices for SWU reached $220 per SWU as of September 30, 2025, a 13% increase since the beginning of the year and 547% over the 2018 low, reflecting strong market conditions.
• The global nuclear industry outlook has improved, with 70 reactors under construction worldwide and projections for substantial growth in nuclear energy generation.

Negatives

• The LEU segment's gross profit turned into a loss of $7.8 million in Q3 2025, a significant decrease from a $5.2 million profit in Q3 2024, primarily due to a 69% decrease in the average price of SWU sold.
• The Technical Solutions segment's gross profit decreased by 5% in Q3 2025 and 24% for the nine months, partly due to undefinitized fees for extended Phase 2 work under the HALEU Operation Contract.
• Long-term debt significantly increased with the issuance of $805.0 million in 0% Convertible Notes and $402.5 million in 2.25% Convertible Notes, increasing financial leverage.
• Supply chain challenges with 5B Cylinders caused delays in HALEU production, leading to an extension of the HALEU Operation Contract Phase 2 through October 31, 2025.
• The estimated cost for Option 1b of the HALEU Operation Contract is insufficient, requiring a revised cost proposal and negotiation, which could indicate potential cost overruns or reduced scope.
• The Russian Decree rescinded TENEX's general license to export LEU to the U.S., requiring specific export licenses for each shipment, creating uncertainty and potential delays in supply.
• The Import Ban Act bans imports of LEU from Russia, requiring waivers, and will cut off supply after 2027, posing a significant risk to the LEU business which relies heavily on TENEX.
• Increasing quantities of LEU imported into the U.S. from China could negatively impact the competitive landscape and future LEU/SWU sales.
• Potential for significant tariffs or trade restrictions on processed critical minerals, including uranium, from international suppliers, which could increase costs.
• Challenges in accepting U.S. dollar payments by TENEX's financial institutions due to sanctions have led to delayed payments.
• Potential for new service fees on Chinese-built vessels used by the shipper of Russian LEU, which could be cost-prohibitive and impact transportation.
• Executive Order 14154 pausing federal funding distribution, including IRA funds, creates uncertainty for the 48C tax credit and other government programs.
• The company's ability to deploy LEU and/or HALEU enrichment is subject to the availability of funding and/or off-take commitments, which are not guaranteed.
• The nuclear fuel market remains oversupplied when Russian supply is included, and future demand for nuclear power generation still faces uncertainty.

Risks

• Geopolitical conflicts and the imposition of sanctions or other measures by the U.S. or foreign governments (e.g., EU, Russia) could directly or indirectly impact financial position or ability to obtain, deliver, transport, or sell LEU or its components.
• Inability to secure additional U.S. government waivers from the Import Ban Act in a timely manner or at all to continue importing Russian LEU under the TENEX Supply Contract beyond 2025.
• TENEX's refusal or its prohibition or inability to deliver, or timely deliver, LEU due to sanctions, payment issues, Russian government directives, or failure to secure specific export licenses under the Russian Decree.
• Disputes with third parties, including contractual counterparties, could result if timely deliveries of LEU under the TENEX Supply Contract are not received.
• Dependence on others, such as TENEX and Orano, and other suppliers (transporters, fabricators, converters) for goods and services, and any resulting negative impact on liquidity.
• Inability to sell, transport, or deliver procured LEU due to sanctions or limitations on imports, including those imposed under the RSA, Import Ban Act, and Russian Decree.
• Increasing quantities of LEU being imported into the United States from China and the potential impact on future LEU or SWU sales or ability to finance enrichment capacity expansion.
• Changes in laws, tariffs, or other government measures that would lift, lower, or relax restrictions on LEU importation from Russia or other countries, or increase its cost.
• Inability to sell Russian LEU available for purchase under the TENEX Supply Contract for import in 2026 or 2027 due to customers having filled their fuel needs.
• Uncertainty regarding whether or when government funding or demand for HALEU for government or commercial uses will materialize and at what level.
• Risks regarding funding for continuation and deployment of the American Centrifuge technology.
• Inability to perform and absorb costs under the HALEU Operation Contract, obtain new contracts and funding, or perform under other agreements.
• Risks that the full benefit of the HALEU Operation Contract may not be obtained, or the HALEU enrichment facility may not be operated to produce HALEU after contract completion, or its output may not be available as a future supply source.
• Existing or new trade barriers limiting the ability to procure LEU for, or sell, transport, or deliver LEU to, customers.
• Pricing trends and demand in the uranium and enrichment markets and their impact on profitability.
• Movement and timing of customer orders causing significant variability in operating results.
• Significant competition from major LEU producers who may be less cost-sensitive or are wholly or partially government-owned.
• Limited ability to compete in foreign markets due to policies favoring indigenous suppliers.
• Revenue largely dependent on a small number of largest customers.
• Backlog uncertainty, including customer actions under current contracts and in future contracting attributable to market conditions, global events, or lack of current production capability.
• Natural and other disasters, including the continued impact of the March 2011 earthquake and tsunami in Japan, on the nuclear industry and business.
• Financial difficulties experienced by customers or suppliers, including possible bankruptcies, insolvencies, or other situations affecting their ability to pay or perform.
• Pandemics, endemics, and other health crises.
• Impact and potential extended duration of a supply/demand imbalance in the market for LEU.
• DOE not issuing any major task orders to any contract awardee under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• The company not winning additional task orders under the HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract to expand the capacity of the American Centrifuge plant.
• DOE not providing an adequate share of the appropriated funding to the company under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• Inability to secure financing to expand the plant for LEU or HALEU or expand it to a commercially viable level.
• DOE not exercising additional options under Phase 3 of the HALEU Operation Contract or awarding a third party to continue the HALEU Operation Contract.
• Inability to increase capacity for HALEU or LEU in a timely manner to meet market demand or contractual obligations.
• DOE not awarding any contracts to the company in response to future proposals.
• Reliance on the only firm with necessary permits and capability to transport LEU from Russia to the United States, and that firm's ability to maintain those permits or secure additional permits.
• Ongoing government shutdown or lack of funding that could result in program cancellations, disruptions, stop work orders, and limit the U.S. government's ability to make timely payments.
• Changes to the U.S. government's appropriated funding levels for the HALEU Operation Contract due to policy changes or other reasons.
• Uncertainty regarding the ability to commercially deploy competitive enrichment technology.
• Potential for demobilization or termination of the HALEU Operation Contract.
• Inability to timely complete obligated work.
• The government's inability to satisfy its obligations, including supplying government-furnished equipment or processing security clearance applications.
• Inability to obtain government approval to extend the term or scope of permitted activities under the lease with the DOE in Piketon, Ohio.
• Security, including cybersecurity, incidents that may impact business operations.
• Inability to perform under fixed-price and cost-share contracts, including higher-than-expected costs and compliance with stringent government contractual requirements.
• Inability to attract qualified employees necessary for the planned expansion of operations in Oak Ridge, Tennessee, or Piketon, Ohio.
• Long-term liabilities, including defined benefit pension plan obligations and postretirement health and life benefit obligations.
• 0% and 2.25% Convertible Notes maturing in 2032 and 2030, respectively, and the significant cash required to service this debt.
• Revenue and operating results fluctuating significantly from quarter to quarter and year to year.
• Impact of financial market conditions on business, liquidity, prospects, pension assets, and insurance facilities.
• The company's capital concentration.
• Value of intangible assets related to LEU segment's backlog and customer relationships.
• Decisions made by Class B Common Stock stockholders regarding their investment, potentially based on factors unrelated to company performance.
• A small number of Class A Common Stock holders potentially exerting significant influence with misaligned interests.
• Risks related to the use of NOL carryforwards and NUBILs to offset future taxable income and the Rights Agreement to prevent an ownership change.
• Failures or security, including cybersecurity, breaches of information technology systems.
• Inability to attract and retain key personnel.
• Inability to obtain new business opportunities or achieve market acceptance of products and services, or obsolescence of products/services by competitors.
• Actions, including investigations, reviews, or audits, by the U.S. government, Russian government, or other governments affecting contractual performance.
• Inability to perform and receive timely payment under agreements with the DOE or other government agencies.
• How aligned the company may be, or perceived to be, with any political party, administration, or its policies.
• Changes or termination of agreements with the U.S. government or other counterparties, or the exercise of contract remedies.
• The competitive environment for products and services.
• Changes in the nuclear energy industry.
• The competitive bidding process associated with obtaining contracts, including government contracts.
• Potential strategic transactions that could be difficult to implement, disrupt business, or change the business profile significantly.
• Outcome of legal proceedings and other contingencies, including the Joppa Power Plant D&D claim and class action lawsuits related to the Portsmouth GDP site.
• Impact of, or changes to, government regulation and policies or interpretation of laws or regulations.
• Recent U.S. federal government administrations' reliance on executive orders to implement regulatory or trade policy and objectives, exacerbating unpredictability.
• Accidents during the transportation, handling, or processing of toxic hazardous or radioactive material.
• Claims and litigation arising from past activities at sites currently operated or no longer operated.
• The conditional conversion feature of 0% and 2.25% Convertible Notes, if triggered, may adversely affect financial condition and operating results by requiring cash settlement or reclassification to current liability.
• Conversion of 0% or 2.25% Convertible Notes may dilute the ownership interest of stockholders or otherwise depress the price of common stock.
• Certain provisions in the indentures governing the 0% and 2.25% Convertible Notes may delay or prevent an otherwise beneficial takeover attempt.
• Servicing debt requires a significant amount of cash, and the company may not have sufficient cash flow from its business to pay its debt, potentially requiring asset sales, debt restructuring, or additional financing.

Future Outlook

The company anticipates having adequate liquidity to support business operations for at least the next 12 months. It plans a major expansion of uranium capacity in Piketon, Ohio, for both LEU and HALEU, which would require multi-billion dollar private and public investment. The company is also investing $60.0 million over 18 months to expand centrifuge manufacturing in Oak Ridge, Tennessee. The ultimate scale and timing of these expansions depend on funding availability and off-take commitments. The global nuclear industry outlook has improved, with projections for substantial growth in nuclear energy generation, but the market for uranium enrichment remains oversupplied when Russian supply is included. The company expects to monetize the $62.4 million 48C clean energy tax credit allocation.

Management Comments

• Our objective is to provide value through the reliability and diversity of our supply sources.
• Our Technical Solutions segment is committed to the restoration of America's domestic uranium enrichment production capability in order to play a critical role in meeting U.S. national security and energy security requirements and advancing America's nonproliferation, energy, and climate objectives.
• Our goal is to deliver major components of the next-generation nuclear fuels that will provide reliable carbon-free power around the world.
• We believe our investments in advanced enrichment technology and our progress in demonstrating HALEU production will position the Company to meet the needs of government and commercial customers in the future as they deploy advanced reactors and next generation fuels and also offers potential cost synergies for a return to LEU production.
• Centrus is exploring the opportunity to deploy LEU enrichment alongside HALEU enrichment to meet a range of commercial and U.S. government requirements, which would bring cost synergies while increasing revenue opportunities.
• Centrus is seeking public and private funding to deploy new production capacity at its Piketon, Ohio plant to help meet the need for new, domestic supplies of enriched uranium.
• We are also actively considering and expect to consider potential strategic transactions from time to time, which could involve, without limitation, acquisitions and/or dispositions of businesses or assets, joint ventures or investments in businesses, products or technologies or changes to our capital structure.

Industry Context

The global nuclear industry outlook has improved, driven by efforts to lower greenhouse gas emissions and increasing interest in nuclear power as a reliable, carbon-free energy source. The World Nuclear Association reports 70 reactors under construction globally, with half in China. The International Energy Agency projects substantial growth in global nuclear energy generation. However, the uranium enrichment market remains oversupplied when Russian supply is included, and without it, the market would be undersupplied, threatening some reactors. The Import Ban Act and Russian Decree have heightened market uncertainty and driven SWU spot prices to $220 per SWU, a 547% increase since 2018. The U.S. government is actively supporting domestic nuclear fuel production, including HALEU and LEU, through significant appropriations and IDIQ contracts, which Centrus is participating in. There's also a focus on advanced reactors and small modular reactors that will require HALEU. However, increasing imports of enriched uranium from China pose a competitive threat.

Comparison to Industry Standards

• SWU spot prices reached $220 per SWU as of September 30, 2025, surpassing the previous historic high of $195 per SWU in December 2024 and significantly above the August 2018 low of $34 per SWU. This indicates a strong market recovery and demand for enrichment services compared to historical benchmarks.
• The global nuclear industry has 70 reactors under construction worldwide as of September 2025, with approximately half in China, reflecting a global trend towards nuclear energy expansion.
• The International Energy Agency's 2024 World Energy Outlook projects global nuclear generation to grow by 18% by 2030 and 47% by 2040 under the Stated Policies scenario, and more than double by 2040 under the Net Zero Emissions by 2050 scenario, indicating a robust long-term growth outlook for the industry.
• Russian enrichment plants represent 43% of the world's capacity, and without Russian supply, the global market for uranium enrichment would be undersupplied, highlighting a critical supply vulnerability that Centrus aims to address with its domestic expansion plans.

Management Changes

Corporate Governance

Legal Proceedings

• DOE informally asserted that Centrus (Enrichment Corp.) is responsible for approximately $9.6 million of Decontamination & Decommissioning (D&D) costs for the Joppa Power Plant under the Power MOU. The company is assessing the assertion and has not formed an opinion on the merits or estimated potential liability.
• A class action complaint (McGlone Plaintiffs) was filed in May 2019 (amended multiple times) alleging off-site contamination from activities at the Portsmouth GDP site, seeking damages. The court dismissed claims for minor children but allowed other claims to proceed. Discovery is ongoing. Centrus believes its operations complied with NRC regulations and expects indemnification under the Price-Anderson Act.
• The Lykins Complaint was filed in June 2022 alleging radiation release from Portsmouth GDP caused Brayden Lykins's death from leukemia, seeking monetary damages. Centrus believes its operations complied with NRC regulations and expects indemnification under the Price-Anderson Act.
• The Rose Complaint was filed in March 2023 alleging radiation release from Portsmouth GDP caused Christian Rose's cancer, seeking monetary damages. Centrus believes its operations complied with NRC regulations and expects indemnification under the Price-Anderson Act.
• The Shaw Complaint was filed in November 2023 (amended) alleging radiation exposure from Portsmouth GDP caused Joshua Shaw's Acute Myeloid Leukemia (AML) and other injuries, seeking monetary damages. The court did not grant Centrus's motion to dismiss for being time-barred. Centrus believes its operations complied with NRC regulations and expects indemnification under the Price-Anderson Act.

Related Party Transactions

• The Russian government-owned entity TENEX is a major supplier of Separative Work Units (SWU) to the Company under the TENEX Supply Contract.
• The Company entered into the Orano Supply Agreement with Orano Cycle, a French state-owned company, for the long-term supply of SWU.

Stakeholder Impact

• Shareholders face potential for dilution from convertible notes if converted, but benefit from increased net income and investment income, long-term value preservation through the Rights Agreement, and potential for significant growth from domestic enrichment expansion.
• Employees will see continued employment and potential for new jobs from expansion in Piketon and Oak Ridge, along with the preservation of the unique workforce at the Technology and Manufacturing Center.
• LEU customers will experience continued supply of LEU, but with risks related to Russian supply disruptions (Import Ban Act, Russian Decree) and potential need for diversification of sources.
• Technical Solutions customers, including the U.S. government, will continue to receive HALEU and technical services under existing contracts, with potential for new contracts and expanded services.
• Suppliers will see continued engagement with existing partners (e.g., Orano) and potential for new suppliers for domestic enrichment expansion.
• Creditors face an increased debt burden from convertible notes, but the company's strong cash position provides liquidity and potential for debt repurchase/refinancing.
• Regulatory authorities will continue to engage with the company for compliance with SEC, DOE, and NRC regulations, as well as for contracts, funding, and waivers.
• Communities in Piketon, Ohio, and Oak Ridge, Tennessee, will experience a positive impact from planned multi-billion dollar investment and job creation for uranium enrichment expansion.

Next Steps

• Complete outstanding change orders for the HALEU Operation Contract Phase 2 by October 31, 2025.
• Negotiate and definitize the fee for the extended Phase 2 period of performance of the HALEU Operation Contract.
• Submit a revised cost proposal for Option 1b of the HALEU Operation Contract for review and negotiation prior to DOE's consideration.
• Continue to pursue additional waivers from the Import Ban Act for LEU imports from Russia for 2026 and 2027.
• Monitor TENEX's ability to secure specific export licenses from Russian authorities for each LEU shipment through December 31, 2025.
• Review payment processing options with TENEX to address challenges in accepting U.S. dollar payments.
• Continue investing approximately $60.0 million over an 18-month period for the expansion of centrifuge manufacturing capacity at the Oak Ridge, Tennessee facility.
• Provide evidence to the IRS within two years (from January 10, 2025) that the requirements for the $62.4 million 48C credit allocation have been met.
• Notify the DOE within two years of certification that the qualified investment in eligible property for the 48C credit is placed in service.
• Compete for additional task orders under the HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract.
• Explore opportunities to deploy LEU enrichment alongside HALEU enrichment in Piketon, Ohio.
• Seek public and private funding and/or off-take commitments for the planned multi-billion dollar expansion of uranium capacity in Piketon, Ohio.
• Continue to evaluate opportunities to grow the business organically or through acquisitions and other strategic transactions.
• Monitor the impact of Executive Order 14154 on federal funding and the 48C tax credit.
• Monitor the Section 232 investigation by the Department of Commerce into critical minerals and potential tariffs.
• Monitor the USTR's position on service fees for Chinese-built vessels used by the shipper of Russian LEU.

Key Dates

Recommendation

The company's strong net income growth, significant increase in cash and investment income, and the release of a federal tax valuation allowance indicate improved financial health. The substantial backlog and strategic initiatives to expand domestic uranium enrichment capacity for both LEU and HALEU, supported by government contracts and a large tax credit, position Centrus for long-term growth in a critical and increasingly strategic industry. While there are geopolitical and supply chain risks, the company is actively managing these through waivers and diversification efforts. The current market conditions for SWU are favorable, and the company's moves to secure domestic supply are strategically sound, making it an attractive investment for long-term growth despite the inherent risks.

Keywords

Uranium Enrichment, HALEU, LEU, Nuclear Fuel, Centrus Energy, Financial Results, Convertible Notes, DOE Contracts, Supply Chain, Russia Sanctions, Import Ban Act, Piketon Ohio, Oak Ridge Tennessee, Restricted Stock Units, Executive Compensation, Q3 2025, Energy Security, Clean Energy